Background: Microtia is a congenital ear hypoplasia associated with auricular defects. Conventional treatment involves implanted costal cartilage. The impact of surgical invasion and donor-site morbidity can be particularly severe in pediatric patients, and the collectable volume of autologous cartilage is limited. The authors therefore developed a new technique for microtia and applied it to treat four patients. Methods: Through the development of a multilayer chondrocyte culture system and two-stage implantation technique, the authors successfully generated human ears. In culture, the chondrocytes are expanded to a sufficiently large volume, produce rich chondroid matrix, and form immature cartilaginous tissues. In the authors' two-stage implantation, the cultured chondrocytes are injection-implanted into the lower abdomen of the patient, where the cells grow into a large, newly generated cartilage with neoperichondrium in 6 months. This cartilage is harvested surgically, sculptured into an ear framework, and implanted subcutaneously into the position of the new ear. Results: The cultured chondrocytes formed a mature cartilage block with sufficient elasticity for use as an auricular cartilage. The formed block had the same histologic origin as elastic cartilage. The ear framework produced from this block was implanted into the auricular defect area, and an auricle with a smooth curvature and shape was subsequently configured. In the 2 to 5 years of postoperative monitoring, the neocartilage maintained good shape, without absorption.
M
icrotia is a congenital ear hypoplasia associated with auricular defects, with a frequency of approximately one in every 6000 births. 1, 2 For auricular reconstruction, implantation of costal cartilage is generally performed. [3] [4] [5] [6] [7] [8] The most significant problem in costal cartilage implantation-the conventional treatment method for auricle reconstruction-is the heavy burden on the donor site. 9, 10 To avoid costal cartilage harvesting, various methods of chondrocyte culture have been investigated in vitro in an attempt to obtain a sufficiently large volume of cells. However, monolayer culture has never been successful. Vacanti et al. 11 developed a tissue-engineering method for obtaining cartilage tissues from a limited number of chondrocytes; in this method, the cells are seeded onto a scaffold made of a synthesized degradable polymer. Many experimental studies using this method have attempted to achieve the regeneration of the elastic tissues and shape of the human ear. [12] [13] [14] However, satisfactory results that are clinically applicable have not yet been obtained because cartilage tissues are not generated uniformly in the scaffold. In addition, because the synthesized polymer of the scaffold induces inflammation when it is absorbed in vivo, it causes absorption of the regenerated cartilage. This technique also has a risk of scaffold exposure because the skin on the temporal region is thin and sufficient blood circulation is difficult to maintain.
We therefore invented a multilayer culture system using 10% autoserum and fibroblast growth factor (FGF)-2 that is suited to the culture of auricular chondrocytes. 15, 16 Using this system, the cells can be cultured in multilayers and a large volume of chondrocytes is obtainable. In our cultures, the auricular chondrocytes themselves generate a rich gelatinous chondroid matrix and form immature cartilage-like tissues in vitro. When these cultured cells together with the gelatinous chondroid matrix were implanted subcutaneously into nude mice, they formed a mature cartilage even though a scaffold was not used. This method has already been applied clinically to craniofacial reconstruction and nasal augmentation, and successful results have been achieved. [15] [16] [17] We further studied how a cartilage block of the size of an auricle could be generated from cultured cells. Because past studies on nude mice revealed that 6 months was necessary for injected chondrocytes to generate a cartilage block, direct injection-implantation into the temporal region was thought to be unsuccessful in the formation of matured cartilage in situ. We therefore developed two-stage implantation, in which chondrocytes are implanted in the first-stage into the lower abdomen, which is a well-vascularized area, and then we wait for 6 months until the cells generate neocartilage with neoperichondrium. It is then harvested surgically, formed into an ear framework, and implanted into the temporal region for the auricle construction. This two-stage implantation technique would be useful not only for auricle construction using auricular chondrocytes but also for a wide range of generative operations using other types of cells.
PATIENTS AND METHODS
This study was approved by the Ethical Committee of Osaka City General Medical Center. Results of previous studies, the purpose of this study, and the results of clinical application in craniofacial augmentation and repair were explained thoroughly to the patients and their parents, who gave their written informed consent.
Four children, aged 9 and 10 years, underwent this treatment; two of them were underweight for their age and did not have good costal cartilage, and all of them wanted to avoid donor-site burden.
Cartilage creation using two-stage implantation of cultured auricular chondrocytes was selected to solve these patient-specific issues.
In all four cases, the auricular remnant was used as the source of the chondrocytes in the culture process. Autologous serum was obtained from each patient at the time of surgical collection of the remnant cartilage. Tests performed in all patients for human immunodeficiency virus, hepatitis B, hepatitis C, human T-cell leukemia virus-1, and Treponema pallidum hemagglutination yielded negative results. The culture medium was examined and confirmed to be free of contamination and bacterial infections once per week.
Multilayer Chondrocyte Culture System
The harvested remnant (approximately 2 ϫ 1 cm
2 ) ( Fig. 1 , left) was sterilized and treated with 0.3% collagenase (Worthington Biochemical, Freehold, N.J.) in a phosphate-buffered saline solution at 4°C overnight. It was spun with a stirrer for 4 hours at 37°C, and filtered through a cell strainer of 100-m pore size (BD Biosciences, Bedford, Mass.), and then the chondrocytes were isolated. The obtained chondrocytes were seeded at a cell density of 1 ϫ 10 3 to 10 4 cells/cm 2 in a 75-cm 2 culture flask, cultured, and then subcultured. At the third passage, cell counts were approximately 1000 times larger than the primary culture. The cells at the second or third passage were used for implantation. The medium was a Dulbecco's Modified Eagle Medium supplemented with 10% autoserum, FGF-2 (5 ng/ml, FIBRAST; Kaken Pharmaceuticals, Tokyo, Japan), and antibiotics containing penicillin G (400 units/ml; Meiji Seika Kaisha, Ltd., Tokyo, Japan), streptomycin sulfate (1 mg/ml; Meiji Seika Kaisha), and amphotericin B (2.5 g/ml; Invitrogen Co., Paisley, United Kingdom). FGF-2 is clinically approved and used as a wound-healing agent in Japan. Finally, the chondrocytes obtained from the subculture were seeded at a density of 1 ϫ 10 4 cells/cm 2 three to four times over the previously seeded cells as described earlier. 15, 16 The chondrocytes cultured in this medium were proliferated in a dedifferentiated state ( Fig. 1, center) , and then the redifferentiated chondrocytes in multilayer culture were obtained (Fig. 1,  right) . The cultured chondrocytes were washed once with phosphate-buffered saline, collected, drawn into a syringe, and implanted. It took approximately 4 weeks from the primary culture to implantation into the patient. The number of chondrocytes in 1 cc of gel was 0.5 to 1 ϫ 10 7 cells. The final volume of gelatinous-formed cells was 10 to 50
Plastic and Reconstructive Surgery • September 2009 cc, with a total of 0.5 to 5 ϫ 10 8 cells. Before implantation, the culture medium was checked for bacteria and mycoplasma to confirm it was free of contamination. The growth factor was removed 48 hours before implantation, and the cells were cultured in the medium alone. Chondrocytes cultured in this manner were also cryopreserved for possible future use.
Two-Stage Implantation Technique Procedure
In our two-stage implantation, approximately 1 month after the start of culturing, the cultured auricular chondrocytes with gelatinous chondroid matrix are implanted by injection into a subcutaneous pocket on the fascia of the lower abdomen using a 16-gauge indwelling needle (Terumo, Tokyo, Japan) (Fig. 2, above, left) . The chondrocytes are injected in one spot. A 40-to 60-cc injection fills the subcutaneous pocket, which is sized to match the injection volume. Patients are given 1 g of cefazolin before the injection and then kept on oral antibiotics (penicillin, 500 mg/day) for 5 days after the injection. Patients are not allowed to perform any heavy exercise (e.g., running, lifting heavy weights) for 2 weeks until chondrocytes take a hardened form. Daily activities or light exercise are not affected.
Six months later, a solid newly generated cartilage block forms subcutaneously in the lower abdomen (Fig. 2, above, right) . This cartilage block is surgically harvested in the sixth month (Fig. 2, below, left and right), sculptured into an ear framework, and reimplanted into the temporal region (Fig. 3) .
Histologic Analysis
Histologic examinations were performed on the cultured chondrocytes in vitro (before implantation) and on the cartilage block collected 6 months after implantation into the abdomen. The specimens underwent Alcian blue staining, toluidine blue staining, immunohistochemical staining of anti-human type II collagen (Chemicon International, Temecula, Calif.), and elastica van Gieson staining.
RESULTS
In every patient, the chondrocyte count was 0.5 to 1 ϫ 10 7 cells/cc. The volumes of implanted cells were 40 cc for patient 1, 62 cc for patient 2, 74 cc for patient 3, and 65 cc for patient 4. The morphology of the cultured chondrocytes in vitro showed layered and redifferentiated chondrocytes (Fig. 1, right) . The cultured chondrocytes with gelatinous chondroid matrix implanted into the abdomen formed a mature neocartilage block with sufficient strength and elasticity for use as auricular cartilage tissue (Fig. 2, below, left and  right) , and an ear framework was sculptured from this tissue (Fig. 3, left) .
Immunohistochemistry determined the presence of human type II collagen, which shows the formation of human cartilage (Fig. 4, left and cen- Volume 124, Number 3 • Generation of Ears in Microtia Treatment ter). Elastica van Gieson staining presented elastic fibers, which showed that the cartilage block was elastic cartilage (Fig. 4, right) . These findings together confirmed that the block was elastic cartilage originating from the auricle remnant and that the cultured chondrocytes displayed normal differentiation after the injection-implantation.
An ear framework produced from this cartilage block was implanted into the auricular defect area on the head to regenerate the complex shape of the ear (Figs. 5 through 8 ). Monitoring for 2 to 5 years after chondrocyte implantation revealed no absorption of the chondrocytes in vivo. Two of the four patients have already undergone the required split-thickness skin grafting on the implanted neocartilage after ear elevation. The skin graft took fully in each case. Because skin graft does not take without the presence of perichondrium-like tissue around the new cartilage, this result indicates that neoperichondrium-like tissue with vascular supply is generated around the neocartilage. Using this technique, we finally achieved successful generation of human ear from auricular chondrocytes (Figs. 5 through 8 ).
DISCUSSION
In conventional reconstruction surgery, costal hyaline cartilage has been used in the reconstruction of elastic cartilage of the ear. Our new technique uses cultured auricular elastic chondrocytes. The strong proliferation of cultured chondrocytes results in a sufficiently large volume of cells for implantation. The major advantages of our technique are the chondrocytes' ability to redifferentiate after implantation into the body, and the lower level of surgical invasion and postoperative discomfort.
To date, chondrocytes have usually been cultured in a monolayer, in which their expansion is limited and the cells dedifferentiate during the cul- 18, 19 Many attempts have been made to redifferentiate the dedifferentiated chondrocytes by using a culture system in agarose gel, alginate beads, collagen gel, 20, 21 high-density cultures, 22 or growth factors. [23] [24] [25] In our technique, the chondrocytes are cultured in multiple layers where the cells redifferentiate, 15, 16 and the multilayered chondrocytes form an aggregate with a gelatinous chondroid matrix. Because of these features, the chondrocytes become a mature neocartilage after implantation, and this realizes the reconstruction of the auricle, which requires a large volume of Volume 124, Number 3 • Generation of Ears in Microtia Treatment cartilage tissues. Because a matured cartilage block could not be formed in vitro, the cultured chondrocytes were implanted into the lower abdomen, where the cells formed a rich matrix and developed into a sufficiently large solid block of matured cartilage in a 6-month period. The human body provided the foothold necessary for the chondrocytes to become cartilage tissues, and al- After implantation into the lower abdomen, the chondrocytes formed auricle-derived elastic cartilage that expressed type II collagen, aglycon, and elastic fibers. Type II collagen is regarded as Fig. 7 . Patient 3, a 9-year-old girl, (left) preoperatively and (right) 2 years 6 months after implantation into the lower abdomen and 2 years after implantation into the temporal area. The preoperative photograph shows the final appearance after implantation of the sculptured ear neocartilage framework and before ear elevation. The patient's course has been favorable, and there has been no absorption of the cartilage. Fig. 8 . Patient 4, a 9-year-old boy, (left) preoperatively and (right) 2 years 6 months after implantation into the lower abdomen and 2 years after implantation into the temporal area. The preoperative photograph shows the final appearance after implantation of the sculptured ear neocartilage framework and before ear elevation. The patient's course has been favorable, and there has been no absorption of the cartilage.
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Grafting of cultured autologous auricular chondrocytes offers important advantages: (1) large volumes of elastic cartilage are obtainable; (2) the chance of rejection is minimal because the cells are autologous; (3) the donor specimen used is the patient's ear remnant, and this minimizes the physical burden caused by harvesting donor tissue; (4) surgery time and hospital stay are shortened because the costal cartilage is left intact; (5) surgical invasion and donor-site morbidity are minimal; and (6) reconstruction of the deformed ear becomes possible for all pediatric patients regardless of their physical growth level. However, treated patients must be monitored for a longer period to check for absorption and deformation of the implanted cartilage. However, even if absorption occurs, additional cultured chondrocytes can be easily implanted using cryopreserved cells.
The most important aspect of this new treatment method is the formation of human auricles from autologous human cells. Only four cases are reported in this study, and techniques for shaping the regenerated ear need to be further studied and refined. However, we believe this novel treatment method offers tangible benefits and significant advantages over traditional methods because it avoids repeated and severe surgical burden on children and ensures successful ear regeneration, two of the main clinical goals of microtia treatment. The concept of our technique can have other applications in the field of reconstruction surgery and in the repair of other physical defects.
